Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06329843 · ClinicalTrials.gov registry record
Intermountain Inpatient Bilirubin Decision Accuracy Study Using Smartphone-based Measurements by Picterus Jaundice Pro
A clinical trial of Neonatal Jaundice, sponsored by Picterus AS.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT06329843: Recruiting study of Neonatal Jaundice, sponsored by Picterus AS.
NCT06329843 is a study of Neonatal Jaundice that is actively recruiting participants, run by Picterus AS. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06329843, a study of Neonatal Jaundice, is actively recruiting participants, sponsored by Picterus AS.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to evaluate the performance of Picterus Jaundice Pro in an American population, including preterm and term newborns and pre- and post- phototherapy.
Conditions Studied
Interventions
- DEVICE Picterus Jaundice Pro (JP)
Study Locations (1)
Utah
- Intermountain Health - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-02-12 |
| Est. Completion | 2024-05 |
What NCT06329843 shows while recruiting
NCT06329843 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Neonatal Jaundice appearing as the primary indexed condition, and to 1 intervention - of which Picterus Jaundice Pro (JP) is the first listed.
NCT06329843 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT06329843 about?
NCT06329843 is a clinical study titled "Intermountain Inpatient Bilirubin Decision Accuracy Study Using Smartphone-based Measurements by Picterus Jaundice Pro". The goal of this project is to evaluate the performance of Picterus Jaundice Pro in an American population, including preterm and term newborns and pre- and post- phototherapy.
What is the current status of trial NCT06329843?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-02-12. Estimated completion is 2024-05.
What conditions does trial NCT06329843 study?
This clinical trial studies the following conditions: Neonatal Jaundice.
What interventions are being tested in trial NCT06329843?
The interventions under investigation include: Picterus Jaundice Pro (JP) (DEVICE).
Who is sponsoring clinical trial NCT06329843?
This trial is sponsored by Picterus AS, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06329843 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neonatal Jaundice
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI